A Phase IIB Trial of Docetaxel Concurrent with Radiation Therapy Plus Hormonotherapy Versus Radio Hormonotherapy in High-Risk Localized Prostate Cancer: Late Toxicity Analysis

Foro, P.Maldonado, J.Bonet, M.Jove-Teixido, J.Rovirosa, A.Sancho Pardo, G.Mira Flores, M.Bejar Luque, A.Carles, J.2025-01-072025-01-072018-11-010360-3016https://hdl.handle.net/10668/25357enA Phase IIB Trial of Docetaxel Concurrent with Radiation Therapy Plus Hormonotherapy Versus Radio Hormonotherapy in High-Risk Localized Prostate Cancer: Late Toxicity Analysisconference outputopen access10.1016/j.ijrobp.2018.06.2571879-355Xhttp://www.redjournal.org/article/S0360301618312586/pdf447811602453